Florida, Lorna P.
HRN: 21-30-48 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/02/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/02/2022
05/08/2022
IVT
3g
Q6hours
S/P Tahbs, Unspecified Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft TissueUnspecified SepsisMultiple Infections (tick All Sites) Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes